Metabolic Disorder Therapeutics Market Landscape 2026–2036
Major pharmaceutical companies are making substantial investments in research and development, concentrating on targeted therapies for conditions that have long been considered untreatable. With recent regulatory approvals for breakthrough therapies and a steady rise